Phase4 Ventures is a global life science investor whose mission is to provide a premium rate of return for investors by creating, identifying and investing in development stage healthcare companies through its dedicated fund. Phase4 Ventures invests in biopharma, specialty pharmaceutical and medical device companies in the US and Europe.

The team of seven investment professionals has experience in medical, scientific, legal and financial disciplines, with a core expertise in structuring investments appropriate for the stage of the company. The Phase4 Ventures team has worked together for over eight years and possesses a high degree of knowledge, professional expertise and networks in healthcare, finance and investment management. The team is complemented by three venture partners who assist in deal sourcing, diligence and post investment management. Phase4 Ventures also leverages an extensive group of advisors with operating experience at a senior level in pharmaceutical and biotechnology companies.